Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Mar 2026 for CORCEPT THERAPEUTICS INC, €2.2M. Read the official filing
Filing timeline
BuySaleG. Leonard Baker Jr.
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+130.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
G. Leonard Baker Jr.: trading record in brief
G. Leonard Baker Jr. is a declared insider of Corcept Therapeutics Inc (board member), with filings sourced from SEC (Form 4). The record holds 7 filings, for trades running from 18 May 2021 to 17 March 2026.
On the market, this insider has only ever bought: 2 purchases, €3.1M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 2 option exercises. 2026 to date brings 1 purchase and no sales.
The latest filing, published on 19 March 2026, reports an open-market purchase of €2.2M in Corcept Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to G. Leonard Baker Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
75,782 shares@ US$33.002267.5% of flowCommon StockSEC:0001201715-26-000007:0
Canonical exit: 15 Jun 2026 (T+90)
30,000 shares@ US$5.864.4% of flowCommon StockSEC:0001201715-26-000005:0
00Common StockSEC:0001201715-26-000003:0
00Common StockSEC:0001225208-25-000061:0
00Common StockSEC:0001225208-23-007580:0
50,000 shares@ US$21.5326.3% of flowCommon StockSEC:0001225208-21-009444:0
Canonical exit: 9 Sept 2021 (T+90)
30,000 shares@ US$6.554.8% of flowCommon StockSEC:0001225208-21-008372:0
7 of 7 declarations
